VivoSeq
Other

Healing

1

Pipeline Programs

10

Active Trials

2

Companies Involved

Healing is an early-stage landscape with 1 program across 2 companies. The most active players are AbbVie, Effexus Pharmaceutical.

Pipeline Metrics

Competitive Density

29/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

96/100

Attrition Rate

2/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

45

clinical trials

Completed27 · 60%
Unknown status7 · 16%
Not yet recruiting5 · 11%
Recruiting2 · 4%
Active, not recruiting2 · 4%
Withdrawn1 · 2%
Other1 · 2%

Trial Activity

45 trials

Healing Osteoarthritic Joints in the Wrist With Adult ADRCs
Active, not recruiting·IInGeneron, Inc.·N/A·NCT03503305·40 enrolled
Osteoimplant and Bone Healing
Not yet recruiting·UUniversidad de Granada·Phase 1·NCT06664060·60 enrolled
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
Not yet recruiting·LLanZhou University·Phase 4·NCT07312370·120 enrolled
Topical CBD Scar Healing Study
Not yet recruiting·UUniversity of Oklahoma·Phase 1·NCT06129591·22 enrolled
Evaluation for Healing of Iatrogenic Perforation After Repair With Different Materials
Enrolling by invitation··Phase 4·NCT06976411·30 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)